BG Medicine, Inc. (OTCPK: BGMD)
Health Care · Life Sciences Tools & Services · US
$—
— today · — 1Y
BG Medicine, Inc. (OTCPK: BGMD) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $11.00 and employs 5 people.
trading between 0.00 and 0.00.
Tweenvest scores BG Medicine, Inc. across four factors: quality 36/100, value 33/100. Its strongest factor is quality.
BGMD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.00
- Revenue (TTM)
- $1.57M
- P/E
- —
- EPS
- -0.72
- Dividend yield
- —
- Beta (5Y)
- 65.16
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.37M
- Employees
- 5
- Next earnings
- —
About BG Medicine, Inc.
BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio includes the BGM Galectin-3 Test, an in vitro diagnostic solution that quantifies galectin-3 levels in blood serum or plasma using an enzyme-linked immunosorbent assay (ELISA) on a microtiter plate platform. Additionally, the company provides the CardioSCORE Test, a multi-analyte, biomarker-based blood test designed to assess the short-term risk of atherothrombotic cardiovascular events, such as myocardial infarction (heart attack) and ischemic stroke. BG Medicine maintains licensing, development, and commercialization agreements with major partners like Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc., specifically for automated versions of its galectin-3 test. Furthermore, it has forged a strategic alliance with Abbott Laboratories to jointly develop and market galectin-3 assay kits, along with their corresponding control kits and calibrators. Founded in 2000, the company was initially known as Beyond Genomics, Inc., before rebranding to BG Medicine, Inc. in October 2004. Its corporate headquarters are located in Waltham, Massachusetts.
- ISIN
- US08861T2069
- Founded
- 2000
- Listed since
- Feb 4, 2011
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| EVIO, Inc.OTCPK: EVIO | $20.73K | $0.00 | — |
| Quick-Med Technologies, Inc.OTCPK: QMDT | $18.67K | $— | — |
| Pressure BioSciences, Inc.OTCPK: PBIO | $8.59K | $0.00 | +100.00% |
| 0913693 B.C. Ltd.OTCPK: REPC.F | $7.36K | $— | — |
| Arrayit CorporationOTCPK: ARYC | $1.13K | $0.00 | — |
| Telesis Bio, Inc.OTCPK: TBIO | $180.00 | $0.00 | -90.00% |
| Response Genetics, IncOTCPK: RGDX.Q | $39.00 | $— | — |
| Deltagen Inc.OTCPK: DGEN | $33.00 | $— | — |
Figures last refreshed Oct 4, 2026.